229 related articles for article (PubMed ID: 21494759)
21. Association of KRAS polymorphisms with risk for lung adenocarcinoma accompanied by atypical adenomatous hyperplasias.
Kohno T; Kunitoh H; Suzuki K; Yamamoto S; Kuchiba A; Matsuno Y; Yanagitani N; Yokota J
Carcinogenesis; 2008 May; 29(5):957-63. PubMed ID: 18299280
[TBL] [Abstract][Full Text] [Related]
22. Epigenetic patterns in the progression of esophageal adenocarcinoma.
Eads CA; Lord RV; Wickramasinghe K; Long TI; Kurumboor SK; Bernstein L; Peters JH; DeMeester SR; DeMeester TR; Skinner KA; Laird PW
Cancer Res; 2001 Apr; 61(8):3410-8. PubMed ID: 11309301
[TBL] [Abstract][Full Text] [Related]
23. Molecular alterations in atypical adenomatous hyperplasia occurring in benign and cancer-bearing lungs.
Gradowski JF; Mantha GS; Hunt JL; Dacic S
Diagn Mol Pathol; 2007 Jun; 16(2):87-90. PubMed ID: 17525677
[TBL] [Abstract][Full Text] [Related]
24. Progressive changes in the protein expression profile of alveolar septa in early-stage lung adenocarcinoma.
Kimura T; Akazawa T; Mizote Y; Nakamura H; Sakaue M; Maniwa T; Shintani Y; Honma K; Tahara H; Okami J
Int J Clin Oncol; 2024 Jun; 29(6):771-779. PubMed ID: 38600426
[TBL] [Abstract][Full Text] [Related]
25. Aberrant CpG island hypermethylation of multiple genes in prostate cancer and prostatic intraepithelial neoplasia.
Kang GH; Lee S; Lee HJ; Hwang KS
J Pathol; 2004 Feb; 202(2):233-40. PubMed ID: 14743506
[TBL] [Abstract][Full Text] [Related]
26. The ACIN1 gene is hypermethylated in early stage lung adenocarcinoma.
Shu Y; Iijima T; Sun W; Kano J; Ishiyama T; Okubo C; Anami Y; Tanaka R; Fukai S; Noguchi M
J Thorac Oncol; 2006 Feb; 1(2):160-7. PubMed ID: 17409846
[TBL] [Abstract][Full Text] [Related]
27. CpG island methylation profile of pancreatic intraepithelial neoplasia.
Sato N; Fukushima N; Hruban RH; Goggins M
Mod Pathol; 2008 Mar; 21(3):238-44. PubMed ID: 18157091
[TBL] [Abstract][Full Text] [Related]
28. Hypermethylation of CpG island loci and hypomethylation of LINE-1 and Alu repeats in prostate adenocarcinoma and their relationship to clinicopathological features.
Cho NY; Kim BH; Choi M; Yoo EJ; Moon KC; Cho YM; Kim D; Kang GH
J Pathol; 2007 Feb; 211(3):269-77. PubMed ID: 17139617
[TBL] [Abstract][Full Text] [Related]
29. Differential methylation landscape of pancreatic ductal adenocarcinoma and its precancerous lesions.
Bararia A; Dey S; Gulati S; Ghatak S; Ghosh S; Banerjee S; Sikdar N
Hepatobiliary Pancreat Dis Int; 2020 Jun; 19(3):205-217. PubMed ID: 32312637
[TBL] [Abstract][Full Text] [Related]
30. Differentiation of atypical adenomatous hyperplasia and adenocarcinoma of the lung by use of DNA ploidy and morphometric analysis.
Yokozaki M; Kodama T; Yokose T; Matsumoto T; Mukai K
Mod Pathol; 1996 Dec; 9(12):1156-64. PubMed ID: 8972475
[TBL] [Abstract][Full Text] [Related]
31. Epidermal growth factor receptor mutation and pathologic-radiologic correlation between multiple lung nodules with ground-glass opacity differentiates multicentric origin from intrapulmonary spread.
Chung JH; Choe G; Jheon S; Sung SW; Kim TJ; Lee KW; Lee JH; Lee CT
J Thorac Oncol; 2009 Dec; 4(12):1490-5. PubMed ID: 19844187
[TBL] [Abstract][Full Text] [Related]
32. DNA methylation profiles of gastric carcinoma characterized by quantitative DNA methylation analysis.
Kang GH; Lee S; Cho NY; Gandamihardja T; Long TI; Weisenberger DJ; Campan M; Laird PW
Lab Invest; 2008 Feb; 88(2):161-70. PubMed ID: 18158559
[TBL] [Abstract][Full Text] [Related]
33. Pathomic Features Reveal Immune and Molecular Evolution From Lung Preneoplasia to Invasive Adenocarcinoma.
Chen P; Rojas FR; Hu X; Serrano A; Zhu B; Chen H; Hong L; Bandyoyadhyay R; Aminu M; Kalhor N; Lee JJ; El Hussein S; Khoury JD; Pass HI; Moreira AL; Velcheti V; Sterman DH; Fukuoka J; Tabata K; Su D; Ying L; Gibbons DL; Heymach JV; Wistuba II; Fujimoto J; Solis Soto LM; Zhang J; Wu J
Mod Pathol; 2023 Dec; 36(12):100326. PubMed ID: 37678674
[TBL] [Abstract][Full Text] [Related]
34. A subset of lung adenocarcinomas and atypical adenomatous hyperplasia-associated foci are genotypically related: an EGFR, HER2, and K-ras mutational analysis.
Sartori G; Cavazza A; Bertolini F; Longo L; Marchioni A; Costantini M; Barbieri F; Migaldi M; Rossi G
Am J Clin Pathol; 2008 Feb; 129(2):202-10. PubMed ID: 18208799
[TBL] [Abstract][Full Text] [Related]
35. Genome-scale meta-analysis of DNA methylation during progression of lung adenocarcinoma.
Zhang QH; Dai XH; Dai ZM; Cai YN
Genet Mol Res; 2015 Aug; 14(3):9200-14. PubMed ID: 26345853
[TBL] [Abstract][Full Text] [Related]
36. Frequent silencing of the candidate tumor suppressor TRIM58 by promoter methylation in early-stage lung adenocarcinoma.
Kajiura K; Masuda K; Naruto T; Kohmoto T; Watabnabe M; Tsuboi M; Takizawa H; Kondo K; Tangoku A; Imoto I
Oncotarget; 2017 Jan; 8(2):2890-2905. PubMed ID: 27926516
[TBL] [Abstract][Full Text] [Related]
37. DNA methylation and RNA expression profiles in lung adenocarcinomas of never-smokers.
Mansfield AS; Wang L; Cunningham JM; Jen J; Kolbert CP; Sun Z; Yang P
Cancer Genet; 2015 May; 208(5):253-60. PubMed ID: 25650174
[TBL] [Abstract][Full Text] [Related]
38. Genetic relationship among atypical adenomatous hyperplasia, bronchioloalveolar carcinoma and adenocarcinoma of the lung.
Morandi L; Asioli S; Cavazza A; Pession A; Damiani S
Lung Cancer; 2007 Apr; 56(1):35-42. PubMed ID: 17241687
[TBL] [Abstract][Full Text] [Related]
39. Evolution of DNA methylome from precancerous lesions to invasive lung adenocarcinomas.
Hu X; Estecio MR; Chen R; Reuben A; Wang L; Fujimoto J; Carrot-Zhang J; McGranahan N; Ying L; Fukuoka J; Chow CW; Pham HHN; Godoy MCB; Carter BW; Behrens C; Zhang J; Antonoff MB; Sepesi B; Lu Y; Pass HI; Kadara H; Scheet P; Vaporciyan AA; Heymach JV; Wistuba II; Lee JJ; Futreal PA; Su D; Issa JJ; Zhang J
Nat Commun; 2021 Jan; 12(1):687. PubMed ID: 33514726
[TBL] [Abstract][Full Text] [Related]
40. Genomic landscape of allelic imbalance in premalignant atypical adenomatous hyperplasias of the lung.
Sivakumar S; San Lucas FA; Jakubek YA; McDowell TL; Lang W; Kallsen N; Peyton S; Davies GE; Fukuoka J; Yatabe Y; Zhang J; Futreal PA; Fowler J; Fujimoto J; Ehli EA; Hawk ET; Wistuba II; Kadara H; Scheet P
EBioMedicine; 2019 Apr; 42():296-303. PubMed ID: 30905849
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
